Catalyst Wire Dossier Catalyst Wire Dossier

Mipomersen

mipomersen · Kastle Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Mipomersen, covering 2013-03-21 to 2019-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol [Phase 3]

See pricing